{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:26:22Z","timestamp":1790339182330,"version":"4.1.0"},"reference-count":80,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPD"],"published-print":{"date-parts":[[2015,9,14]]},"DOI":"10.3233\/jpd-150604","type":"journal-article","created":{"date-parts":[[2015,9,14]],"date-time":"2015-09-14T14:29:40Z","timestamp":1442240980000},"page":"659-667","source":"Crossref","is-referenced-by-count":91,"title":["Neuropsychiatric Symptoms in Parkinson\u2019s\u00a0Disease"],"prefix":"10.1177","volume":"5","author":[{"given":"Dag","family":"Aarsland","sequence":"first","affiliation":[{"name":"Karolinska Institute, Department of Neurobiology, Care Sciences and Society (NVS), H1, Division of Neurogeriatrics, Huddinge, Sweden"},{"name":"Stavanger University Hospital, Stavanger, Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milica Gregoric","family":"Kramberger","sequence":"additional","affiliation":[{"name":"Karolinska Institute, Department of Neurobiology, Care Sciences and Society (NVS), H1, Division of Neurogeriatrics, Huddinge, Sweden"},{"name":"Department of Neurology, University Medical Center Ljubljana, Slovenia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JPD-150604_ref1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/jnnp.67.4.492","article-title":"Range of neuropsychiatric disturbances inpatients with Parkinson\u2019s disease","volume":"67","author":"Aarsland","year":"1999","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson\u2019s disease: A critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.3233\/JPD-150604_ref3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.23528","article-title":"Symptomatology and markers of anxiety disorders in Parkinson\u2019s disease: A cross-sectional study","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1176\/jnp.16.1.29","article-title":"Differential DSM-III psychiatric disorder prevalence profiles in dystonia and Parkinson\u2019s disease","volume":"16","author":"Lauterbach","year":"2004","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.3233\/JPD-150604_ref5","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1007\/s00415-004-0483-3","article-title":"Psychiatric aspects of Parkinson\u2019s disease\u2013an update","volume":"251","author":"Schrag","year":"2004","journal-title":"J Neurol"},{"key":"10.3233\/JPD-150604_ref6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jagp.2013.02.020","article-title":"Neuropsychiatric symptoms inParkinsondisease and dementia with Lewy bodies: What geriatric psychiatrycan learn","volume":"21","author":"Weintraub","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JPD-150604_ref7","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1177\/0891988703256053","article-title":"Recognition and treatment of depression in parkinson\u2019s disease","volume":"16","author":"Weintraub","year":"2003","journal-title":"J Geriatric Psychiatry Neurol"},{"key":"10.3233\/JPD-150604_ref8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1177\/0891988713481269","article-title":"Barriers to mental health care utilization in Parkinson\u2019s disease","volume":"26","author":"Dobkin","year":"2013","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"10.3233\/JPD-150604_ref9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/j.1600-0404.2006.00579.x","article-title":"A systematic review of depression and mental illness preceding Parkinson\u2019s disease","volume":"113","author":"Ishihara","year":"2006","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JPD-150604_ref10","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1212\/WNL.40.10.1513","article-title":"An estimate of the incidence of dementia in idiopathic Parkinson\u2019s disease","volume":"40","author":"Mayeux","year":"1990","journal-title":"Neurology"},{"key":"10.3233\/JPD-150604_ref11","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/archneur.61.12.1906","article-title":"The rate of cognitive decline in Parkinson disease","volume":"61","author":"Aarsland","year":"2004","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150604_ref12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","article-title":"Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort","volume":"130","author":"Williams-Gray","year":"2007","journal-title":"Brain: J Neurol"},{"key":"10.3233\/JPD-150604_ref13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/jnnp-2012-303419","article-title":"Non-motor symptoms in early Parkinson\u2019sdisease: A 2-year follow-up study on previously untreatedpatients","volume":"84","author":"Erro","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","article-title":"Prognosis ofmild cognitive impairment in early Parkinson disease: TheNorwegian ParkWest study","volume":"70","author":"Pedersen","year":"2013","journal-title":"JAMA Neurol"},{"key":"10.3233\/JPD-150604_ref15","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson\u2019s disease","volume":"82","author":"Brown","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref16","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/mds.25886","article-title":"Reduced dopamine transporter bindingpredates impulse control disorders in Parkinson\u2019s disease","volume":"29","author":"Vriend","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref17","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/mds.21333","article-title":"Depression rating scales in Parkinson\u2019s disease: Critique and recommendations","volume":"22","author":"Schrag","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mds.20723","article-title":"Provisional diagnostic criteria for depression in Parkinson\u2019s disease: Report on NINDS\/NIMH Work Group","volume":"21","author":"Marsh","year":"2006","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/mds.23184","article-title":"Anxiety rating scales in Parkinson\u2019s disease: A validation study of the Hamilton Anxiety Rating Scale, the Beck Anxiety Inventory and the Hospital Anxiety and Depression Scale","volume":"26","author":"Leentjens","year":"2011","journal-title":"Mov Disord"},{"issue":"Pt 6","key":"10.3233\/JPD-150604_ref20","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson\u2019s disease: Loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.3233\/JPD-150604_ref21","first-page":"42","article-title":"Anxiety disorders in Parkinson\u2019s disease","volume":"96","author":"Richard","year":"2005","journal-title":"Adv Neurol"},{"key":"10.3233\/JPD-150604_ref22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/mds.870080415","article-title":"Anxiety and motor performance in Parkinson\u2019s disease","volume":"8","author":"Siemers","year":"1993","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref23","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0404.1993.tb04068.x","article-title":"\u201cPanic attacks\u201d in Parkinson\u2019s disease. A long-term complication of levodopa therapy","volume":"87","author":"Vazquez","year":"1993","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JPD-150604_ref24","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1097\/00146965-200312000-00004","article-title":"Correlates of generalized anxiety and panic attacks in dystonia and Parkinson disease","volume":"16","author":"Lauterbach","year":"2003","journal-title":"Cogn Behav Neurol"},{"key":"10.3233\/JPD-150604_ref25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.72.2.241","article-title":"Health related quality of life in Parkinson\u2019s disease: A systematic review of disease specific instruments","volume":"72","author":"Marinus","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.25873","article-title":"Psychiatric issues in cognitive impairment","volume":"29","author":"Aarsland","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref27","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.jagp.2013.09.006","article-title":"Anxiety has specific syndromal profiles inParkinsondisease: A data-driven approach","volume":"22","author":"Starkstein","year":"2013","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JPD-150604_ref28","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson\u2019s disease","volume":"82","author":"Brown","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref29","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00415-010-5465-z","article-title":"Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson\u2019s disease","volume":"257","author":"Riedel","year":"2010","journal-title":"J Neurol"},{"key":"10.3233\/JPD-150604_ref30","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.20324","article-title":"Sydney multicentre study of parkinson\u2019s disease: Non-L-dopa-responsive problems dominate at 15 years","volume":"20","author":"Hely","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref31","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jns.2009.08.014","article-title":"Epidemiology of psychosis in Parkinson\u2019s disease","volume":"289","author":"Fenelon","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.3233\/JPD-150604_ref32","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1177\/0897190011426556","article-title":"Atypical antipsychotic drugs in the treatment of Parkinson\u2019s disease","volume":"24","author":"Friedman","year":"2011","journal-title":"J Pharm Pract"},{"key":"10.3233\/JPD-150604_ref33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/nrneurol.2009.62","article-title":"Hallucinations in Parkinson disease","volume":"5","author":"Diederich","year":"2009","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JPD-150604_ref34","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.JGP.0000192480.89813.80","article-title":"Characteristics of visual hallucinations in Parkinson diseasedementia and dementia with lewy bodies","volume":"14","author":"Mosimann","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JPD-150604_ref35","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/jnnp.2010.234799","article-title":"Feeling of presence in Parkinson\u2019s disease","volume":"82","author":"F\u00e9nelon","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref36","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1136\/jnnp-2011-300043","article-title":"Psychosis associated to Parkinson\u2019s disease inthe early stages: Relevance of cognitive decline and depression","volume":"83","author":"Morgante","year":"2012","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref37","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A 12-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150604_ref38","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1212\/01.WNL.0000068010.82167.CF","article-title":"Longitudinal outcome of Parkinson\u2019s disease patients with psychosis","volume":"60","author":"Factor","year":"2003","journal-title":"Neurology"},{"issue":"Pt 4","key":"10.3233\/JPD-150604_ref39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1093\/brain\/123.4.733","article-title":"Hallucinations in Parkinson\u2019s disease: Prevalence, phenomenology and risk factors","volume":"123","author":"F\u00e9nelon","year":"2000","journal-title":"Brain"},{"key":"10.3233\/JPD-150604_ref40","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/mds.20263","article-title":"Hallucinations in Parkinson\u2019s disease: A follow-up study","volume":"20","author":"de Maindreville","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.parkreldis.2013.04.026","article-title":"Cognitive correlates of visual hallucinations in non-dementedParkinson\u2019s disease patients","volume":"19","author":"Hepp","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-150604_ref42","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/mds.20582","article-title":"Relationship between hallucinations, delusions, and rapid eye movement sleep behavior disorder in Parkinson\u2019s disease","volume":"20","author":"Pacchetti","year":"2005","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1001\/archneur.60.3.387","article-title":"Prevalence and characteristics of dementia in Parkinson disease: An 8-year prospective study","volume":"60","author":"Aarsland","year":"2003","journal-title":"Arch Neurol"},{"key":"10.3233\/JPD-150604_ref44","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2165\/00002512-200825080-00004","article-title":"Pathophysiology and treatment of psychosis in Parkinson\u2019s disease: A review","volume":"25","author":"Zahodne","year":"2008","journal-title":"Drugs Aging"},{"key":"10.3233\/JPD-150604_ref45","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/mds.21316","article-title":"Characteristics of apathy in Parkinson\u2019s disease","volume":"22","author":"Dujardin","year":"2007","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref46","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/mds.26208","article-title":"Apathy in Parkinson\u2019s disease: A systematic review and meta-analysis","volume":"30","author":"den Brok","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref47","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1136\/jnnp.73.6.636","article-title":"Apathy in Parkinson\u2019s disease","volume":"73","author":"Pluck","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JPD-150604_ref48","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1002\/mds.26058","article-title":"Apathy in untreated early-stage Parkinson disease: Relationship with other non-motor symptoms","volume":"29","author":"Dujardin","year":"2014","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.parkreldis.2013.09.006","article-title":"Impulsive and compulsive behaviors among Danish patients with Parkinson\u2019s disease: Prevalence, depression, and personality","volume":"20","author":"Callesen","year":"2014","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JPD-150604_ref50","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/cercor\/bhj043","article-title":"Apathy and the functional anatomy of the pre-frontal cortex-basal ganglia circuits","volume":"16","author":"Levy","year":"2006","journal-title":"Cereb Cortex"},{"key":"10.3233\/JPD-150604_ref51","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/brain\/awq032","article-title":"Non-motor dopamine withdrawal syndrome after surgery for Parkinson\u2019s disease: Predictors and underlying mesolimbic denervation","volume":"133","author":"Thobois","year":"2010","journal-title":"Brain"},{"key":"10.3233\/JPD-150604_ref52","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/mds.22505","article-title":"Impulsive and compulsive behaviors in Parkinson\u2019s disease","volume":"24","author":"Evans","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref53","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/gps.2291","article-title":"Evidence for an association of the big five personalityfactors with recurrence of depressive symptoms in later life","volume":"24","author":"Steunenberg","year":"2009","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JPD-150604_ref54","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/mds.21803","article-title":"A systematic review of prevalence studies of depression in Parkinson\u2019s disease","volume":"23","author":"Reijnders","year":"2008","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref55","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0006-3223(02)01347-1","article-title":"Risk factors for suicide in later life","volume":"52","author":"Conwell","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JPD-150604_ref56","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/jnnp.2007.130583","article-title":"Attempted and completed suicidesafter subthalamic nucleus stimulation for Parkinson\u2019s disease","volume":"79","author":"Soulas","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"Pt 10","key":"10.3233\/JPD-150604_ref57","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1093\/brain\/awn214","article-title":"A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson\u2019s disease","volume":"131","author":"Voon","year":"2008","journal-title":"Brain"},{"key":"10.3233\/JPD-150604_ref58","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1212\/WNL.59.3.408","article-title":"Nonmotor fluctuations in Parkinson\u2019s disease: Frequent and disabling","volume":"59","author":"Witjas","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JPD-150604_ref59","first-page":"1","article-title":"Development of a non-motor fluctuation assessment instrument for Parkinson disease","volume":"19","author":"Kleiner-Fisman","year":"2011","journal-title":"Parkinson Dis"},{"key":"10.3233\/JPD-150604_ref60","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.26067","article-title":"EuroInf: A multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson\u2019s disease","volume":"30","author":"Martinez-Martin","year":"2015","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref61","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: A multicenter assessment of nonmotor symptoms and theirimpact on quality of life in Parkinson\u2019s disease","volume":"24","author":"Barone","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref62","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1212\/WNL.0b013e318285c0ed","article-title":"Nonmotor fluctuations in Parkinson disease: Severity and correlation with motor complications","volume":"80","author":"Storch","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JPD-150604_ref63","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1002\/mds.22589","article-title":"Neuropsychiatric symptoms in Parkinson\u2019s disease","volume":"24","author":"Aarsland","year":"2009","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref64","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"10.3233\/JPD-150604_ref65","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1212\/WNL.0b013e3182516244","article-title":"A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease","volume":"78","author":"Richard","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JPD-150604_ref66","doi-asserted-by":"crossref","first-page":"e79510","DOI":"10.1371\/journal.pone.0079510","article-title":"A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson\u2019s disease","volume":"8","author":"Troeung","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JPD-150604_ref67","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1176\/appi.ajp.2011.10111669","article-title":"Cognitive-behavioral therapy for depression in Parkinson\u2019s disease: A randomized, controlled trial","volume":"168","author":"Dobkin","year":"2011","journal-title":"Am J Psychiatry"},{"key":"10.3233\/JPD-150604_ref68","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1037\/a0027695","article-title":"Predictors of treatment response to cognitive-behavioral therapy for depression in Parkinson\u2019s disease","volume":"80","author":"Dobkin","year":"2012","journal-title":"J Consult Clin Psychol"},{"issue":"Suppl 3","key":"10.3233\/JPD-150604_ref69","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson\u2019s disease. S42-S","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref70","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/mds.25689","article-title":"Clinical issues in the treatment of anxiety and depression in older adults with Parkinson\u2019s disease","volume":"28","author":"Pachana","year":"2013","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref71","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00702-013-0994-0","article-title":"The practical management of cognitive impairment and psychosis in the older Parkinson\u2019s disease patient","volume":"120","author":"Hindle","year":"2013","journal-title":"J Neural Transm"},{"key":"10.3233\/JPD-150604_ref72","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.amjopharm.2012.11.001","article-title":"Atypical antipsychotic use and parkinsonism in dementia:Effects of drug, dose, and sex","volume":"10","author":"Marras","year":"2012","journal-title":"Am J\u00a0Geriatr Pharmacother"},{"key":"10.3233\/JPD-150604_ref73","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/1531-8257(200101)16:1<135::AID-MDS1006>3.0.CO;2-Q","article-title":"Clozapine for the treatment of drug-induced psychosis in Parkinson\u2019s disease: Results of the 12 week open label extension in the PSYCLOPS trial","volume":"16","author":"Factor","year":"2001","journal-title":"Mov Disord"},{"key":"10.3233\/JPD-150604_ref74","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.wnf.0000136891.17006.ec","article-title":"Quetiapine and clozapine in parkinsonian patients withdopaminergic psychosis","volume":"27","author":"Morgante","year":"2004","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JPD-150604_ref75","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","article-title":"Rivastigmine for dementia associated with Parkinson\u2019s disease","volume":"351","author":"Emre","year":"2004","journal-title":"New Engl J Med"},{"key":"10.3233\/JPD-150604_ref76","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(10)70194-0","article-title":"Memantine for patients with Parkinson\u2019s disease dementia or dementia with Lewy bodies: A randomised, double-blind, placebo-controlled trial","volume":"9","author":"Emre","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150604_ref77","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1474-4422(09)70146-2","article-title":"Memantine in patients with Parkinson\u2019s\u00a0disease dementia ordementia with Lewy bodies: A double-blind, placebo-controlled, multicentre trial","volume":"8","author":"Aarsland","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.3233\/JPD-150604_ref78","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0140-6736(13)62106-6","article-title":"Pimavanserin for patients with Parkinson\u2019s disease psychosis: A randomised, placebo-controlled phase 3 trial","volume":"383","author":"Cummings","year":"2014","journal-title":"Lancet"},{"key":"10.3233\/JPD-150604_ref79","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2013-306439","article-title":"Rivastigmine in apathetic but dementia anddepression-free patients with Parkinson\u2019s disease: A double-blind,placebo controlled, randomised clinical trial","volume":"85","author":"Devos","year":"2014","journal-title":"J\u00a0NeurolNeurosurg Psychiatry"},{"issue":"Pt 5","key":"10.3233\/JPD-150604_ref80","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/brain\/awt067","article-title":"Parkinsonian apathy responds todopaminergic stimulation of D2\/D3 receptors with piribedil","volume":"136","author":"Thobois","year":"2013","journal-title":"Brain"}],"container-title":["Journal of Parkinson's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JPD-150604","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:44:18Z","timestamp":1777610658000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JPD-150604"}},"subtitle":[],"editor":[{"given":"Amos D.","family":"Korczyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Heinz","family":"Reichmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"K. Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,9,14]]},"references-count":80,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jpd-150604","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,14]]}}}